Johnson & Johnson (JNJ) P/B (1999 - 2026)
Johnson & Johnson (JNJ) P/B from Nov 1, 1999 to Jul 20, 2026. The TTM Johnson & Johnson (JNJ) P/B is 7.39. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of Johnson & Johnson (JNJ)
| Year | P/B | Change |
|---|---|---|
| 2026 | 7.39 | +20.84% |
| 2025 | 6.11 | +25.51% |
| 2024 | 4.87 | -12.29% |
| 2023 | 5.55 | -10.78% |
| 2022 | 6.22 | -2.90% |
| 2021 | 6.41 | -0.27% |
| 2020 | 6.43 | -0.58% |
| 2019 | 6.46 | +11.54% |
| 2018 | 5.80 | +14.30% |
| 2017 | 5.07 | +17.24% |
| 2016 | 4.32 | +8.82% |
| 2015 | 3.97 | -5.81% |
| 2014 | 4.22 | +21.04% |
| 2013 | 3.49 | +16.91% |
| 2012 | 2.98 | +2.21% |
| 2011 | 2.92 | -1.79% |
| 2010 | 2.97 | -15.70% |
| 2009 | 3.52 | +3.94% |
| 2008 | 3.39 | +71.31% |
| 2007 | 1.98 | +1.03% |
| 2006 | 1.96 | +9.85% |
| 2005 | 1.78 | -5.23% |
| 2004 | 1.88 | +22.76% |
| 2003 | 1.53 | -3.82% |
| 2002 | 1.59 | -9.12% |
| 2001 | 1.75 | +12.46% |
| 2000 | 1.56 | +12.71% |
| 1999 | 1.38 | N/A |
Comparison Johnson & Johnson (JNJ) P/B with competitors
Johnson & Johnson (JNJ) P/B is 7.39.
| Ticker | Name | P/B | Upside |
|---|---|---|---|
| AMRN | Amarin Corp | 0.68 | -90.74% |
| GRFS | Grifols SA | 0.79 | -89.30% |
| SNY | Sanofi | 1.27 | -82.80% |
| BIIB | Biogen Inc | 1.52 | -79.43% |
| PFE | Pfizer Inc | 1.55 | -79.04% |
| OGN | Organon & Company | 3.93 | -46.84% |
| MIRA | Mira Pharmaceuticals Inc | 4.09 | -44.61% |
| GSK | GSK Plc | 4.37 | -40.81% |
| BMY | Bristol-Myers Squibb Company | 6.04 | -18.22% |
| AZN | Astrazeneca plc | 6.20 | -16.05% |
| MRK | Merck & Co Inc | 6.68 | -9.56% |
| GILD | Gilead Sciences Inc | 6.94 | -6.04% |
| NVO | Novo Nordisk | 7.07 | -4.28% |
| NVS | Novartis AG | 7.60 | +2.90% |
| NSRX | Nasus Pharma Ltd | 12.90 | +74.66% |
| MDCX | MDCorp | 15.34 | +107.70% |
| AMGN | AMGEN Inc | 21.17 | +186.63% |
| SCLX | Scilex Holding Company | 28.85 | +290.62% |
| LLY | Lilly(Eli) & Company | 32.94 | +345.99% |
| ABBV | Abbvie Inc | 50.46 | +583.20% |